Company

Advancing predictive drug safety

Cytocast is redefining how drug safety is evaluated and understood. Our mission is to predict clinically relevant side effects early, interpret the mechanisms, and advance better therapies with confidence.

Our Team

A multidisciplinary team of scientists, engineers, and drug discovery experts passionate about transforming drug safety evaluation.

Attila Csikász-Nagy István Reguly Bence Keömley-Horváth Erzsébet Fichó Paul B. Lebeau
Meet the Team

Advisors

Guided by leading experts in pharmacology, systems biology, AI, and drug development.

István Hodász, PharmD György M. Keserű, PhD Bálint Antal, PhD Radouane Oudrhiri, PhD Prof. Alberto Paccanaro
Meet Our Advisors

Careers

Join us in building the future of drug safety. Explore open roles and help shape what's next.

Explore Careers

Our Story

Cytocast was founded by scientists and engineers with a shared belief: drug safety should be predictable. Frustrated by late-stage failures and black-box models, we built the Cytocast DIGITAL TWIN Platform™ to simulate how drugs perturb the human biology network and lead to side effects.

Today, we partner with innovators across the pharma and biotech ecosystem to enable earlier, more confident decisions and create safer medicines for patients.

Founded

2021

Headquarters

Budapest, Hungary

Team

Experts in AI, systems biology, pharmacology & drug discovery

Focus

Predictive drug safety & mechanistic insights

Interested in partnering with Cytocast?

Let's build safer and more effective therapies together.

Contact Us